Correlation Between OWC Pharmaceutical and Phibro Animal

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OWC Pharmaceutical and Phibro Animal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OWC Pharmaceutical and Phibro Animal into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OWC Pharmaceutical Research and Phibro Animal Health, you can compare the effects of market volatilities on OWC Pharmaceutical and Phibro Animal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OWC Pharmaceutical with a short position of Phibro Animal. Check out your portfolio center. Please also check ongoing floating volatility patterns of OWC Pharmaceutical and Phibro Animal.

Diversification Opportunities for OWC Pharmaceutical and Phibro Animal

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between OWC and Phibro is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding OWC Pharmaceutical Research and Phibro Animal Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phibro Animal Health and OWC Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OWC Pharmaceutical Research are associated (or correlated) with Phibro Animal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phibro Animal Health has no effect on the direction of OWC Pharmaceutical i.e., OWC Pharmaceutical and Phibro Animal go up and down completely randomly.

Pair Corralation between OWC Pharmaceutical and Phibro Animal

Given the investment horizon of 90 days OWC Pharmaceutical Research is expected to generate 98.57 times more return on investment than Phibro Animal. However, OWC Pharmaceutical is 98.57 times more volatile than Phibro Animal Health. It trades about 0.19 of its potential returns per unit of risk. Phibro Animal Health is currently generating about 0.04 per unit of risk. If you would invest  0.01  in OWC Pharmaceutical Research on August 26, 2024 and sell it today you would earn a total of  0.00  from holding OWC Pharmaceutical Research or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

OWC Pharmaceutical Research  vs.  Phibro Animal Health

 Performance 
       Timeline  
OWC Pharmaceutical 

Risk-Adjusted Performance

25 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in OWC Pharmaceutical Research are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain fundamental indicators, OWC Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.
Phibro Animal Health 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Phibro Animal Health are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical indicators, Phibro Animal exhibited solid returns over the last few months and may actually be approaching a breakup point.

OWC Pharmaceutical and Phibro Animal Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OWC Pharmaceutical and Phibro Animal

The main advantage of trading using opposite OWC Pharmaceutical and Phibro Animal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OWC Pharmaceutical position performs unexpectedly, Phibro Animal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phibro Animal will offset losses from the drop in Phibro Animal's long position.
The idea behind OWC Pharmaceutical Research and Phibro Animal Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation